ALTANA Focuses on United States.Business Editors NEW YORK/BAD HOMBURG, Germany--(BUSINESS WIRE)--May 22, 2002 As part of its internationalization The support for monetary values, time and date for countries around the world. It also embraces the use of native characters and symbols in the different alphabets. See localization, i18n, Unicode and IDN. internationalization - internationalisation strategy, ALTANA (NYSE NYSE See: New York Stock Exchange : AAA AAA: see American Automobile Association. (Triple A) A common single-cell battery used in a myriad of electronic devices of all variety. Like its double A (AA) cousin, it provides 1.5 volts of DC power. When used in series, the voltage is multiplied. ) is increasing its focus on its most important and largest market: the US, accounting for 21% of Group sales Group sales Block sale (of large amounts) of securities to institutional investors. group sales The distribution of a new security issue to institutional clients. amounting to EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 2.3 billion. US sales totaled close to EUR500 million in 2001 - a year-on-year increase of 44%. ALTANA currently employs a workforce of approximately 1,000 in the United States. ALTANA Pharma: Building strong foundation for the future ALTANA Pharma is represented in the United States by ALTANA Inc., (Melville/New York), where it ranks amongst the leading American manufacturers of generic skin ointments ointments, n.pl semisolid, non–water-based treatments that are not water-soluble and that create protective films to prevent dehydration of the skin. and solutions. ALTANA operates on the market through E. Fougera (generic drugs), Savage Laboratories (ethical drugs) and Pharmaderm (veterinary products). In 2001 the company generated sales of EUR137 million with almost 600 employees. ALTANA's US sales were led by Pantoprazole, the innovative gastrointestinal drug which has been marketed since May 2000 under the brand name Protonix by sales partner Wyeth Inc.. In 2001, Protonix generated US sales of EUR628 million. The market share of new prescriptions in the proton pump inhibitor proton pump inhibitor n. A class of drugs that inhibit gastric acid secretion by interfering with the movement of hydrogen ions across cell membranes and are used mainly to treat peptic ulcers, gastroesophageal reflux disease, and esophagitis. (PPI (1) (Pixels Per Inch) The measurement of the resolution of a monitor or scanner. For example, a monitor that is 16 inches wide and displays 1600 pixels across its width would have a resolution of 100 ppi (1600 divided by 16). ) segment expanded to 14.1% (end of April). Clearly aligned U.S. strategy: own research unit and sales force Within the next few years, the medium-term goal of our U.S. pharmaceuticals strategy is to build ALTANA Pharma (U.S.) into a company with its own independent research and clinical development facilities, as well as a sufficiently large marketing and sales structure. With US market approval expected for its two development candidates, Roflumilast and Ciclesonide, ALTANA aims to gradually establish a strong field sales force. ALTANA Pharma has formed a technology alliance with GPC Biotech (Munich/Martinsried/Germany) in the fields of genomics/proteomics and bioinformatics. Together with our US subsidiary, ALTANA Inc., it will build the ALTANA Research Institute (Waltham/Boston/MA), its own genomics-oriented research center. ALTANA plans to invest approximately US$ 120 million in this project by 2007. This technology transfer will ensure that ALTANA has its own Functional Genomics/Proteomics facility in the United States within the next few years, thereby rounding off its fully integrated research capacity. ALTANA Chemie: Market leader ALTANA Chemie's four subsidiaries occupy leading positions in important US markets and employ a total workforce of 340. In 2001, ALTANA Chemie achieved sales of EUR142 million in the fields of Additives & Instruments, Coatings & Sealants, Varnish & Compounds and Wire Enamels. This is equivalent to 20% of the total sales generated by the Chemicals division. Founded in 1964, BYK-Chemie USA (Wallingford, Connecticut) is the U.S. market leader in its sector. It produces additives for the coatings, inks and plastics industries throughout the entire NAFTA NAFTA in full North American Free Trade Agreement Trade pact signed by Canada, the U.S., and Mexico in 1992, which took effect in 1994. Inspired by the success of the European Community in reducing trade barriers among its members, NAFTA created the world's Zone. BYK BYK Bouake Cote d'Ivoire (Ivory Coast airport code) Gardner USA (Columbia, Maryland), acquired in 1989 under the name Gardner Lab., is one of the leading American suppliers of top quality instruments for measuring color and gloss. ALTANA's acquisition of P.D. George (St. Louis, Missouri) in 1996 established the company as the U.S. market leader in Wire Enamels and Varnish & Compounds, a position which it continues to build on. P.D. George goes back over 80 years and is one of the biggest suppliers to the electrical insulating varnish industry in the US. About the company ALTANA AG is an international pharmaceuticals and chemicals group with sales of EUR2.3 billion in 2001 and over 9,000 employees all over the world. Its Pharmaceuticals division, ALTANA Pharma (Constance), concentrates on the areas Therapeutics, Contrast Media, In-vitro diagnostic products and OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). medication, and focuses on innovative pharmaceutical research (gastroenterology gastroenterology Medical specialty dealing with digestion and the digestive system. In the 17th century Jan Baptista van Helmont conducted the first scientific studies in the field; William Beaumont published his own observations in 1833. , respiratory, oncology). ALTANA Pharma represents a group of about 30 subsidiaries and affiliates in Europe, the Americas and Asia. The Chemicals division ALTANA Chemie develops, produces and sells Additives & Instruments, Coatings & Sealants, Varnish & Compounds and Wire Enamels worldwide. The Chemicals division has more than 20 subsidiaries and affiliates all over the world. This press release contains statements about the future which are obviously subject to certain risks and uncertainties. If the assumptions on which these statements are made are not fulfilled, the effective results may differ from those currently expected. ALTANA cannot accept any responsibility for updating such statements or adapting them to future events or developments. This press release is also available at www.altana.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion